(Q41883282)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16269424%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

case report

0 references

title

Repeated B cell depletion in treatment of refractory systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16269424%20AND%20SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

8 January 2020

main subject

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16269424%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

David A. Isenberg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16269424%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Ng KP

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16269424%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Leandro MJ

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16269424%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Edwards JC

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16269424%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Cambridge G

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16269424%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

English

0 references

publication date

3 November 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16269424%20AND%20SRC:MED&resulttype=core&format=json

Annals of the Rheumatic Diseases

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16269424%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16269424%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16269424%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

942-945

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16269424%20AND%20SRC:MED&resulttype=core&format=json

B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.

8 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798232

From the bench to the bedside: ways to improve rituximab efficacy.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798232

Complement activation determines the therapeutic activity of rituximab in vivo.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798232

Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798232

The 1982 revised criteria for the classification of systemic lupus erythematosus

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798232

Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798232

An open study of B lymphocyte depletion in systemic lupus erythematosus

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798232

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798232

Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16269424

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16269424

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Humanized anti-CD20 monoclonal antibody in the treatment of severe resistant systemic lupus erythematosus in a patient with antibodies against rituximab

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16269424

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ARD.2005.044487

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16269424%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16269424%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

PubMed publication ID

16269424

1 reference